{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:38:19Z","timestamp":1769855899348,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.11.065","type":"journal-article","created":{"date-parts":[[2008,12,7]],"date-time":"2008-12-07T10:24:56Z","timestamp":1228645496000},"page":"726-732","source":"Crossref","is-referenced-by-count":67,"title":["Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa"],"prefix":"10.1016","volume":"27","author":[{"given":"Che-Hung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chun","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Beri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subash","family":"Kapre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayant S.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Bouveret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Marc","family":"LaForce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl E.","family":"Frasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.11.065_bib1","series-title":"Emerging and other Communicable Diseases, surveillance and control, control of epidemic meningococcal diseases, WHO practical guidelines, 2nd ed.","author":"World Health Organization","year":"1998"},{"key":"10.1016\/j.vaccine.2008.11.065_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0035-9203(02)90089-1","article-title":"Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa","volume":"96","author":"Molesworth","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.11.065_bib3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0035-9203(80)90195-9","article-title":"The duration of the antibody response to meningococcal vaccination in an African village","volume":"74","author":"Greenwood","year":"1980","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.11.065_bib4","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(97)03227-3","article-title":"Love\u2019s labours lost\u201d: failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa","volume":"350","author":"Robbins","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.11.065_bib5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00006454-200010000-00001","article-title":"A Rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine","volume":"19","author":"Robbins","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.11.065_bib6","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1056\/NEJMcp063561","article-title":"Prevention of meningococcal disease","volume":"355","author":"Gardner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.11.065_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for vaccine prevention of meningococcal infection","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.11.065_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(85)90224-7","article-title":"Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine","volume":"326","author":"Reingold","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.11.065_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1542\/peds.60.5.673","article-title":"Persistence of antibody following immunization of children with group A and C meningococcal polysaccharide vaccines","volume":"60","author":"Lepow","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2008.11.065_bib10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0264-410X(99)00390-4","article-title":"Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library","volume":"18","author":"Grothaus","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.065_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.065_bib12","unstructured":"Lee CH, Frasch CE. Polysaccharide\u2013protein conjugate vaccine. US Patent pending, US 2007\/0141084 A1."},{"key":"10.1016\/j.vaccine.2008.11.065_bib13","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1016\/j.vaccine.2007.07.037","article-title":"Characterization and immunogenicity of meningococcal group C conjugate vaccine prepared using hydrazide-activated tetanus toxoid","volume":"25","author":"Silveira","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.065_bib14","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1016\/j.vaccine.2007.06.018","article-title":"Comparison of Neisseria meningitidis serogroup W135 polysaccharide\u2013tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide","volume":"25","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.065_bib15","series-title":"Proceedings of the 227th ACS National Meeting","article-title":"A method with increased yield for production of polysaccharide\u2013protein conjugate vaccines using hydrazide chemistry","author":"Lee","year":"2004"},{"key":"10.1016\/j.vaccine.2008.11.065_bib16","series-title":"Proceedings of the 14th international pathogenic Neisseria conference","first-page":"159","article-title":"A novel conjugation process for production of a highly immunogenic group A meningococcal conjugate vaccine for use in Africa","author":"Frasch","year":"2004"},{"key":"10.1016\/j.vaccine.2008.11.065_bib17","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.vaccine.2007.04.049","article-title":"The Meningitis Vaccine Project","volume":"25S","author":"LaForce","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.065_bib18","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0140-6736(03)13494-0","article-title":"Meningococcal conjugate vaccine for Africa: a model for development of new vaccine for the poorest countries","volume":"361","author":"Jodar","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.11.065_bib19","series-title":"Proceedings of the 15th international pathogenic Neisseria Conference","article-title":"The application of physicochemical methods of analysis to the development of conjugate vaccines against meningococcal group A bacteria","author":"Ravenscroft","year":"2006"},{"key":"10.1016\/j.vaccine.2008.11.065_bib20","doi-asserted-by":"crossref","first-page":"A101","DOI":"10.1016\/j.vaccine.2007.04.050","article-title":"Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults","volume":"25S","author":"Kshirsagar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.065_bib21","series-title":"Poster in the conference of the 100th anniversary of the royal society of hygiene and tropical medicine","article-title":"A phase 2, observer blind, randomized study to evaluate the safety and immunogenicity of a new meningococcal group A conjugate vaccine in healthy African toddlers residing in the Meningitis Belt","author":"Sow","year":"2007"},{"key":"10.1016\/j.vaccine.2008.11.065_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0022-1759(86)90280-2","article-title":"Trinitrophenyl\u2013protein conjugates are more complex than it is currently thought","volume":"86","author":"Vidal","year":"1986","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2008.11.065_bib25","series-title":"Handbook of micromethods for the biological sciences. Phosphorus (total), vol. 70","author":"Keleti","year":"1974"},{"key":"10.1016\/j.vaccine.2008.11.065_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2008.11.065_bib27","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/CVI.00341-07","article-title":"Immunity to Neisseria meningitidis group B in serum bactericidal-negative adults","volume":"14","author":"Welsch","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2008.11.065_bib28","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0021-9258(19)42828-7","article-title":"Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance","volume":"249","author":"Bundle","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2008.11.065_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0008-6215(96)00253-4","article-title":"Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production","volume":"296","author":"Lemercinier","year":"1996","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2008.11.065_bib30","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1128\/IAI.66.5.2186-2192.1998","article-title":"Structural properties of group B Streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy","volume":"66","author":"Wessels","year":"1998","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2008.11.065_bib31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0264-410X(92)90046-M","article-title":"Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide-protein conjugate vaccine is decreased by admixture of high dose of free saccharide","volume":"10","author":"Peeters","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.065_bib32","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0264-410X(98)00129-7","article-title":"Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response","volume":"16","author":"Rodriguez","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.11.065_bib33","unstructured":"World Health Organization. Requirements for meningococcal polysaccharide vaccine. World Health Organ. Tech. Rep. Ser. 1976, 594:51\u201377."},{"key":"10.1016\/j.vaccine.2008.11.065_bib34","first-page":"43","article-title":"Enhanced stability of meningococcal polysaccharide vaccines by using lactose as a menstruum for lyophilization","volume":"55","author":"Tiesjema","year":"1977","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2008.11.065_bib35","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1128\/IAI.71.9.5115-5120.2003","article-title":"Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice","volume":"71","author":"Jin","year":"2003","journal-title":"Infect Immunity"},{"key":"10.1016\/j.vaccine.2008.11.065_bib36","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1021\/bi00838a026","article-title":"The derivatization of cross-linked polyacrylamide beads. Controlled introduction of functional groups for the preparation of special-purpose, biochemical adsorbents","volume":"8","author":"Inman","year":"1969","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2008.11.065_bib37","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/IAI.70.7.3707-3713.2002","article-title":"Effect of O-acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune response","volume":"70","author":"Berry","year":"2002","journal-title":"Infect Immunity"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T10:44:22Z","timestamp":1684752262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08015478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08015478"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}